Cryoport, Inc. (CYRX)

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.

Address

112 WESTWOOD PLACE, SUITE 350
BRENTWOOD, TN 37027

Founded

1990

Number of Employees

1,170

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )
- - - - - - - $8,344 $43,794 - - $26,069
Average Price - - - - - - - $27.24 $24.65 - - $25.03
# Shares Purchased - - - - - - - 306,300 1,776,842 - - 1,041,571
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - - - - - -70.6% -67.5% - - -68.0%
S&P 500 Return to Date - - - - - - - 31.7% 37.3% - - 34.5%
Excess Total Return - - - - - - - -102.3% -104.8% - - -102.5%
Quartile Rank
Percentile Rank - - - - - - - 6% 6% - - 8%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)